Femasys Company
.jpeg)
Femasys engages in R&D and manufacture of medical devices for women's healthcare. With an initial focus in the area of reproductive health, their two lead product candidates offer solutions for two ends of the spectrum: FemBloc for permanent birth control and FemaSeed as an artificial insemination infertility treatment.
(Reupload).png)
(Reupload).png)
Technology:
Longevity FemTech
Industry:
Reproductive Health & Contraception
Headquarters:
Suwanee, Georgia, United States
Founded Date:
01-01-2004
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
3
Total Funding:
$63,903,202
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-01-18
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership